American Renal Associates Holdi – Consensus Indicates Potential -13.0% Downside

DirectorsTalk Interviews

American Renal Associates Holdi found using ticker (ARA) now have 3 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 11.5 and 7 calculating the average target price we see 10. Now with the previous closing price of 11.49 this now indicates there is a potential downside of -13.0%. The day 50 moving average is 7.92 and the 200 day moving average is 6.88. The market cap for the company is $397m. Visit the company website at: http://www.americanrenal.com

American Renal Associates Holdings operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index